Carvedilol
Product Images NDC 50090-2555

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-2555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph comparing percent mortality over 21 months between Carvedilol and placebo groups. The x-axis represents time in months, while the y-axis shows percent mortality. The Carvedilol group has a lower mortality rate compared to the placebo group, with a reported P-value of 0.0014 indicating statistical significance.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot displaying hazard ratios with confidence intervals across various patient subgroups, including gender, age groups, race, diabetic status, ischemic condition, heart rate categories, systolic blood pressure levels, and spironolactone usage. The horizontal axis is labeled 'Hazard ratio' ranging from 0.0 to 2.0, showing risk comparisons for these groups.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis line graph from the CAPRICORN study showing percent mortality over 24 months comparing Carvedilol and placebo groups. The graph plots mortality percentage on the y-axis and months on the x-axis, indicating lower mortality in the Carvedilol group versus placebo with a P value of 0.03.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing two forest plots comparing hazard ratios for various patient subgroups. The plots display point estimates and confidence intervals for hazard ratios ranging approximately from 0.4 to 1.3 for each subgroup, including age, gender, time post-myocardial infarction, prior beta-blocker use, Killip classification, thrombolytic therapy, PTCA status, heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure.*
FDA Label Image

Label Image (Lbl500902066)

Label Image (Lbl500902066)
Carvedilol 3.125 mg tablets label from A-S Medication Solutions, Libertyville, IL 60048. The label includes dosage strength, storage instructions to keep at 68 to 77 degrees Fahrenheit protecting from moisture, and package quantity of 60 tablets. It notes each tablet contains carvedilol USP 3.125 mg along with the product number and lot information.*
FDA Label Image

Label Image (Lbl500902119)

Label Image (Lbl500902119)
Label for Carvedilol tablets, 25 mg strength, manufactured by A-S Medication Solutions. The label includes storage instructions, a quantity of 60 tablets, and notes that each tablet contains Carvedilol USP, 25 mg. Additional details include lot number and package identification codes.*
FDA Label Image

Label Image (Lbl500902175)

Label Image (Lbl500902175)
Carvedilol 6.25 mg tablets packaging label from A-S Medication Solutions. The label shows the product number 5975-0, lot information, and storage instructions to keep between 68 to 77 degrees Fahrenheit, protecting from moisture. The package contains 60 tablets.*
FDA Label Image

Label Image (Lbl500902555)

Label Image (Lbl500902555)
Carvedilol 12.5 mg tablets, label from A-S Medication Solutions. The white label indicates each tablet contains 12.5 mg carvedilol. Directions to store at 68 to 77 degrees Fahrenheit and protect from moisture are shown. The package contains 60 tablets, with NDC 50090-2555-0 and lot number 5976-0.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of Carvedilol depicted with its molecular bonds and rings, illustrating the arrangement of atoms in this active ingredient used in the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.